WHO chief Tedros Adhanom Ghebreyesus has lauded Prime Minister Narendra Modi's commitment for supporting vaccine equity and sharing COVID-19 vaccines with over 60 countries across the world, hoping that other nations will follow his example.
In a tweet, Ghebreyesus, Director-General of the World Health Organisation, said that India's support in supplying its vaccines is helping over 60 countries to begin the vaccination process.
"Thanks India & Prime Minister @narendramodi for supporting #VaccinEquity. Your commitment to #COVAX and sharing #COVID19 vaccine doses is helping 60+ countries start vaccinating their #healthworkers and other priority groups. I hope other countries will follow your example," he said in the tweet on Thursday.
India on Wednesday dispatched the first batch of six lakh COVID-19 vaccine doses to the African country of Ghana under the COVAX facility in collaboration with UNICEF, which aims to cover 92 countries under the initiative.
The doses are a part of the first batch of COVID-19 vaccine the country is acquiring through the COVID-19 Vaccine Global Access Facility (COVAX), which Ghana among nearly 92 countries have signed into.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The Ministry of External Affairs (MEA) on February 12 said that India has provided over 229 lakh doses of coronavirus vaccines to various countries out of which 64 lakh doses have been supplied as grant assistance and 165 lakh on commercial basis.
MEA Spokesperson Anurag Srivastava said India will continue to take forward the global vaccine supply initiative and cover more countries in a phased manner.
Consignments of coronavirus vaccine doses were supplied as gifts to Bangladesh (20 lakh), Myanmar (17 lakh), Nepal (10 lakh), Bhutan (1.5 lakh), the Maldives (1 lakh), Mauritius (1 lakh), Seychelles (50,000), Sri Lanka (5 lakh), Bahrain (1 lakh), Oman (1 lakh), Afghanistan (5 Lakhs), Barbados (1 Lakh) and Dominica (70,000), he said.
Srivastava said countries which received vaccines on commercial basis are Brazil (20 lakh), Morocco (60 lakh), Bangladesh (50 lakh), Myanmar (20 lakh), Egypt (50,000), Algeria (50,000), South Africa (10 lakh), Kuwait (2 lakh) and UAE (2 lakh).
The vaccines are even being sent to Latin American countries.
India, the largest drug producer in the world, is currently manufacturing two COVID-19 vaccines- Covishield and Covaxin.While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute of India in Pune, Covaxin is being produced by Bharat Biotech.